Aussie com­pany man­ages to keep man­u­fac­tur­ing at lo­cal level

DEMM Engineering & Manufacturing - - NEWS -

go­ing global, bur­geon­ing sales of the acute pain killer Pen­throx (com­monly known as ‘the green whis­tle’) have led to the cre­ation of 26 jobs and count­ing at Aus­tralian health­care com­pany Med­i­cal De­vel­op­ments In­ter­na­tional (MDI), as well as the launch of a new fa­cil­ity in Scoresby, Mel­bourne.

The more than 1000m2 set-up in­cor­po­rates R&D and Qual­ity Con­trol labs mean­ing MDI can now do the en­tire mf process in-house, man­u­fac­tur­ing, fill­ing and pack­ag­ing the en­tire Pen­throx range on site. Pre­vi­ously a third party was re­spon­si­ble for QC.

The build­ing of a lo­cal state- of-theart fa­cil­ity was made pos­si­ble with the as­sis­tance of Aus­tralia’s Com­mon­wealth Sci­en­tific and In­dus­trial Re­search Or­gan­i­sa­tion (CSIRO) and MDI will con­tinue to work with the na­tional body within its R&D sec­tion, which has been set up to de­velop fu­ture man­u­fac­tur­ing pro­cesses and sup­port ex­ist­ing pro­cesses. As­sisted by CSIRO, MDI has seen its mar­ket value rise from less than AUD10 mil­lion dol­lars in March 2010, to around AUD290 mil­lion now.

The fac­tory has been de­signed with ex­pan­sion options in place. There is the po­ten­tial to in­crease the fa­cil­ity by five times its cur­rent size in or­der to sup­port MDI’s next 5-10 years of growth. MDI’s CEO, John Shar­man said the new man­u­fac­tur­ing fa­cil­ity was built to keep up with global de­mand for the prod­uct, as MDI is the only com­pany in the world mak­ing Pen­throx, which of­fers a safe, sim­ple to use, non-nar­cotic, non-ad­dic­tive al­ter­na­tive for acute pain man­age­ment, fit­ting a sig­nif­i­cant mar­ket need glob­ally.

“Pen­throx has now been ap­proved for sale in the United King­dom, Repub­lic of Ire­land, France and Bel­gium. We’re ex­pect­ing to en­ter an­other 37 mar­kets over the next two years, in­clud­ing Ger­many, Spain and Italy, and com­mence the prod­uct ap­proval process in the USA”, Mr Shar­man said.

Dr Paul Sav­age, CSIRO Bio­med­i­cal Re­search Di­rec­tor, said that as the Aus­tralian man­u­fac­tur­ing in­dus­try tran­si­tions from high vol­ume com­mod­ity prod­ucts to in­no­va­tion-driven high-value ex­ports, it is com­pa­nies like Med­i­cal De­vel­op­ments In­ter­na­tional that are lead­ing the way.

Newspapers in English

Newspapers from New Zealand

© PressReader. All rights reserved.